Life Sciences Advisory

Executive advisory for pharma, biotech, diagnostics, MedTech and digital health leaders navigating complex product, regulatory, evidence, technology and growth decisions.

Life sciences organizations increasingly face decisions that cut across product strategy, regulation, evidence, quality, data, AI and commercialization. PrecisionPulse brings these perspectives together to help leadership teams evaluate tradeoffs, identify critical priorities and move complex programs forward with greater clarity.

• What product, regulatory and evidence pathway best supports the business strategy? 
• Where are the most consequential risks before the next development, regulatory or investment milestone? 
• How should AI, data and digital governance evolve as technologies move into regulated use? 
• How should product and regulatory risk inform portfolio, partnership and market-expansion decisions?

Product & Regulatory Strategy
Global product pathways, regulatory strategy, evidence planning and critical development decisions.

Precision Medicine & Diagnostics
Companion diagnostics, biomarkers, diagnostic strategy and therapeutic-development alignment.

AI, Data & Digital Governance
Governance, accountability and risk controls for AI-enabled products and regulated data environments.

Evidence, Quality & Readiness
Evidence strategy, quality considerations and readiness for critical regulatory and organizational milestones.

Strategic Growth & Partnerships
Partnerships, portfolio priorities, market expansion and strategic growth decisions.

PrecisionPulse works with leadership teams across the life sciences ecosystem:

Pharma & Biotech 

Diagnostics & MedTech 

Digital Health & AI-Enabled Healthcare 

Investors, Boards & Strategic Partners 

Engagements are structured around the decision or milestone at hand, from focused strategic assessments and diligence reviews to ongoing executive advisory.